This year, Dr. Thomas Schinecker, CEO of the Roche Group, steps into his role as President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). His vision centres on strengthening the pharmaceutical industry's crucial role in society: driving innovative solutions that address healthcare systems under pressure while delivering breakthrough medicines that transform patient care.
"I am excited about the potential of medical innovation to transform healthcare and meet the challenges we face today. As we work towards turning scientific progress into the next generation of life-saving medicines and vaccines, I am confident we can build a healthier future for people everywhere, together."
The significance of this mission echoes in IFPMA Director General Dr. David Reddy's reflection: "We are entering a new period of incredible scientific innovation and importance for global health. The breadth of experience our new leadership team brings will be invaluable as we continue to deliver on our priorities."
Read the full announcement about Dr. Schinecker's appointment and vision for advancing global healthcare